This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Charles J. Ruzkowski, MD; Robert A. Sanowski, MD; Janet Austin, RN; Jay J. Rohwedder, MD; J. Patrick Waring, MD

Arch Intern Med. 1992;152(4):783-785.

Abstract
Patients with gastroesophageal reflux disease may have pulmonary symptoms due to repeated aspiration of gastric contents or reflex bronchospasm during a reflux event. Oral bronchodilators are known to worsen gastroesophageal reflux and may lead to a vicious cycle when gastroesophageal reflux causes bronchospasm. The effect of inhaled bronchodilators on gastroesophageal reflux is unknown. We compared the severity of gastroesophageal reflux in patients with documented gastroesophageal reflux disease and obstructive lung disease while they were taking inhaled albuterol or oral theophylline. Nine patients with gastroesophageal reflux disease had 24-hour esophageal pH studies on two separate days approximately 1 week apart. On one study day, the patients received 0.5 mg of albuterol in 2.5 mL of normal saline via hand-held nebulizer, four times a day. On the other day, the patients received sustainedrelease theophylline, 200 mg twice a day, or in a dosage taken previously to achieve a serum theophylline level of 55 to 110 µmol/L. The patients had 40% reduction in the total time the pH was less than 4.0 with albuterol than with theophylline (9.7% vs 16.1%). Seven patients had less gastroesophageal reflux while taking albuterol, and two patients had essentially no change. Patients with gastroesophageal reflux disease, who require bronchodilator therapy for obstructive lung disease, have less reflux with inhaled albuterol.

(Arch Intern Med. 1992;152:783-785)

Author Affiliations
From the Division of Gastroenterology, Carl T. Hayden Veterans Affairs Medical Center, Phoenix, Ariz.

Footnotes
Accepted for publication October 14, 1991.

Reprint requests to Division of Digestive Diseases, Department of Internal Medicine, Emory University School of Medicine, PO Drawer AL, Atlanta, GA 30322 (Dr Waring).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cough {middle dot} 3: Chronic cough and gastro-oesophageal reflux
Fontana and Pistolesi
Thorax 2003;58:1092-1095.
ABSTRACT | FULL TEXT  

Respiratory Symptoms and Nocturnal Gastroesophageal Reflux : A Population-Based Study of Young Adults in Three European Countries
Gislason et al.
Chest 2002;121:158-163.
ABSTRACT | FULL TEXT  

Association between Medications That Relax the Lower Esophageal Sphincter and Risk for Esophageal Adenocarcinoma
Lagergren et al.
ANN INTERN MED 2000;133:165-175.
ABSTRACT | FULL TEXT